Article Text

Download PDFPDF
Original research article
Prevalence and treatment of atrial fibrillation in UK general practice from 2000 to 2016
  1. Nicola Jaime Adderley,
  2. Ronan Ryan,
  3. Krishnarajah Nirantharakumar,
  4. Tom Marshall
  1. Institute of Applied Health Research, University of Birmingham, Birmingham, UK
  1. Correspondence to Dr Tom Marshall, Institute of Applied Health Research, University of Birmingham, Birmingham, B15 2TT, UK; t.p.marshall{at}bham.ac.uk

Footnotes

  • Contributors TM had the original idea for the study. NJA, RR and TM designed the study. RR undertook data extraction. NJA designed and performed the analysis. KN validated the data extraction and analysis. NJA wrote the first draft of the paper, which was revised in collaboration with TM, KN and RR.

  • Funding NJA and TM are funded by the NIHR Collaborations for Leadership in Applied Health Research and Care West Midlands initiative.

  • Disclaimer This paper presents independent research and the views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.

  • Competing interests KN has received personal fees from Sanofi and a grant from AstraZeneca outside the submitted work.

  • Patient consent Not required.

  • Ethics approval Research carried out using THIN data was approved by the NHS South-East Multicentre Research Ethics Committee (MREC) in 2003, subject to independent scientific approval. Approval for this analysis was granted by the Scientific Review Committee (for the use of THIN data), SRC reference number 15THIN021.

  • Provenance and peer review Not commissioned; externally peer reviewed.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors TM had the original idea for the study. NJA, RR and TM designed the study. RR undertook data extraction. NJA designed and performed the analysis. KN validated the data extraction and analysis. NJA wrote the first draft of the paper, which was revised in collaboration with TM, KN and RR.

  • Funding NJA and TM are funded by the NIHR Collaborations for Leadership in Applied Health Research and Care West Midlands initiative.

  • Disclaimer This paper presents independent research and the views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.

  • Competing interests KN has received personal fees from Sanofi and a grant from AstraZeneca outside the submitted work.

  • Patient consent Not required.

  • Ethics approval Research carried out using THIN data was approved by the NHS South-East Multicentre Research Ethics Committee (MREC) in 2003, subject to independent scientific approval. Approval for this analysis was granted by the Scientific Review Committee (for the use of THIN data), SRC reference number 15THIN021.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles